Could tiny molecules in breast milk shape a Baby's food tolerance?
NCT ID NCT07744373
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study looks at whether tiny molecules called microRNAs in breast milk are linked to how well a baby's immune system tolerates food. Researchers will collect breast milk samples at several stages—from early colostrum to mature milk—and also take a small blood sample from infants around 6–9 months old. The goal is to see if these microRNAs relate to regulatory T cells and whether they might influence the development of food tolerance in babies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If certain microRNAs in breast milk are linked to infant food tolerance, this could point toward ways to support allergy prevention or early dietary guidance.
- What could go wrong
- This is a small observational study, so it can only reveal associations, not cause and effect. Findings may not apply broadly beyond the specific group studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study will include healthy lactating mothers and their term infants (≥37 weeks gestation) who are followed at Istanbul University, Istanbul Medical Faculty, Department of Social Pediatrics, Well Child Outpatient Clinic or the Esencan Hospital Outpatient Clinic. Infants must be exclusively breastfed for the first 6 months. Mothers and infants must be willing to provide breast milk and infant blood samples at specified time points and provide informed consent. Infants with chronic illnesses or major congenital anomalies, and mothers unable or unwilling to comply with study procedures, will be excluded.
- Ages
-
0 days to 9 months
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Lactating mothers and their infants attending the Child Health and Diseases Clinic at Istanbul University Faculty of Medicine, or the Child Health and Diseases Clinic at Esencan Hospital. 2. Infants who are exclusively breastfed for the first 6 months. 3. Mothers willing to provide breast milk samples at multiple time points (colostrum, transitional milk, and mature milk at 1, 4, 6, and/or 9 months postpartum). 4. Infants aged 0-9 months, born at term (≥37 weeks gestation) with no major congenital anomalies or chronic illnesses. 5. Mothers and infants who provide informed consent for participation in the study. Exclusion Criteria: 1. Infants who are not exclusively breastfed for the first 6 months. 2. Infants with chronic illnesses or diagnosed immunodeficiency, metabolic, or gastrointestinal disorders. 3. Mothers who are unable or unwilling to provide informed consent. 4. Mothers with chronic illnesses or immunological disorders that may affect breast milk composition.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Food tolerance are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Child Health and Diseases Clinic, Esencan Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
-
İstanbul University İstanbul Medical Faculty Department of Pediatrics Division of Social Pediatrics
RECRUITINGIstanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a bone marrow infusion help kidney transplant patients ditch lifelong pills?
- Could a stem cell transplant free kidney recipients from a lifetime of anti-rejection drugs?
- Gene clues may explain why light therapy helps some transplant patients
- Immune secrets of early pregnancy revealed
- Could a stem cell shot free liver transplant patients from a lifetime of pills?